Literature DB >> 4248913

Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.

F B Taylor, H J Müller-Eberhard.   

Abstract

Dilute whole blood clots were prepared by addition of thrombin to blood diluted 1:10 in phosphate buffer. The pH of this buffer was 7.4 and the ionic strength was 0.084. Though the ionic strength was low, there was no hemolysis of red corpuscles due to the contribution to the osmotic gradient by plasma salts and proteins. In the standard assay the clot was formed by addition of thrombin at 4 degrees C then incubated at 37 degrees C. Retraction and lysis of these clots were inhibited by removal of platelets and by increasing concentrations of purified thrombin. Retraction and lysis were also inhibited by inactivation of any one of the following factors: gammaM globulin, complement components C4 and 3, and (in the case of lysis) plasminogen. Evidence that some of the above serum factors were adsorbed to the platelet membrane was obtained by aggregation of washed platelets by antisera to these factors (i.e. fibrinogen, gammaM, and C4 or C3). These platelets were not aggregated by antisera to other serum proteins (by albumin, transferrin, gammaG globulin). These and other studies suggested that platelets, thrombin, fibrinogen, gammaM globulin (cold agglutinin), complement components, and plasminogen influenced and facilitated retraction and lysis of clots. These studies also suggested that platelets and some of these factors were physically associated. Because of this physical association, and because of the fact that clot retraction is associated with aggregation and retraction of platelets, we extended the above observations to include a study of the effect of these same serum factors on serum-induced aggregation and retraction of washed platelets. (Other terms which have been in use in the past to describe serum-induced platelet aggregation and retraction have included those such as platelet "fusion" and "viscous metamorphosis," neither of which fully described the phenomena.)Platelet aggregation and retraction induced by serum was markedly accelerated by addition of increasing concentrations of thrombin and (or) cold agglutinin. Hirudin and antisera to gammaM globulin inhibited seruminduced aggregation and retraction of platelets. Reconstitution of inactivated serum with purified C4, 3, and 5 and thrombin restored its capacity to induce aggregation and retraction of platelets.Therefore, we postulated that platelet aggregation and retraction were necessary for clot retraction and that platelet aggregation and clot retraction facilitated clot lysis. More specifically we postulated that thrombin, in addition to catalyzing clot formation, also modified the platelet membrane such that gammaM globulin (cold agglutinin) and complement components can act on the platelet membrane leading to (a) aggregation and retraction of the platelets, (b) retraction of the clot, and (c) to the activation of plasminogen either on the surface of the platelet by C8i and (or) by release of platelet activators of plasminogen.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4248913      PMCID: PMC535783          DOI: 10.1172/JCI106425

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES.

Authors:  A L HAINES; I H LEPOW
Journal:  J Immunol       Date:  1964-03       Impact factor: 5.422

2.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

3.  IMMUNOLOGIC STUDIES OF PLATELET PROTEIN.

Authors:  R L NACHMAN
Journal:  Blood       Date:  1965-05       Impact factor: 22.113

4.  Measurements of complement by agglutination of human erythrocytes reacting in immune-adherence.

Authors:  K NISHIOKA
Journal:  J Immunol       Date:  1963-01       Impact factor: 5.422

5.  Factors influencing lysis of whole blood clots.

Authors:  F B Taylor; H J Müller-Eberhard
Journal:  Nature       Date:  1967-12-09       Impact factor: 49.962

6.  Studies of the plasmin system. I. Measurement of human and animal plasminogen; measurement of an activator in human serum.

Authors:  P S NORMAN
Journal:  J Exp Med       Date:  1957-09-01       Impact factor: 14.307

7.  ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

Authors:  U R NILSSON; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

8.  ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; C E BIRO
Journal:  J Exp Med       Date:  1963-09-01       Impact factor: 14.307

9.  Isolation and characterization of two beta1-glycoproteins of human serum.

Authors:  H J MULLER-EBERHARD; U NILSSON; T ARONSSON
Journal:  J Exp Med       Date:  1960-02-01       Impact factor: 14.307

10.  The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.

Authors:  H J Müllerèberhard; A P Dalmasso; M A Calcott
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

View more
  12 in total

1.  Immune response in human subjects at high altitude.

Authors:  I S Chohan; I Singh; K Balakrishnan; G P Talwar
Journal:  Int J Biometeorol       Date:  1975-11       Impact factor: 3.787

2.  A phenomenologic description of clot lysis in dilute human plasma correlating structure and function of platelets.

Authors:  J M Gilliam; V Berkus; F B Taylor
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307

3.  The role of complement in localized shwartzman reaction: studies with congenitally C6-deficient rabbits.

Authors:  J S Fong; K O Rother; R A Good
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

4.  The platelet as an inflammatory cell.

Authors:  R L Nachman; M Polley
Journal:  Trans Am Clin Climatol Assoc       Date:  1979

5.  C1 and human platelets. II. Detection by immunological methods and role.

Authors:  J L Wautier; G M Tobelem; A P Peltier; J P Caen
Journal:  Immunology       Date:  1976-04       Impact factor: 7.397

Review 6.  Relationships among the complement, kinin, coagulation, and fibrinolytic systems.

Authors:  J S Sundsmo; D S Fair
Journal:  Springer Semin Immunopathol       Date:  1983

7.  Hageman factor-independent fibrinolytic pathway.

Authors:  A D Schreiber; K F Austen
Journal:  Clin Exp Immunol       Date:  1974-08       Impact factor: 4.330

8.  Plasmin inhibition of platelet function and of arachidonic acid metabolism.

Authors:  A I Schafer; B Adelman
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

9.  Lysosomotropic agents selectively potentiate thrombin-induced acid hydrolase secretion from platelets.

Authors:  B A Van Oost; J B Smith; H Holmsen; G D Vladutiu
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

10.  Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets.

Authors:  O A Hamad; K N Ekdahl; P H Nilsson; J Andersson; P Magotti; J D Lambris; B Nilsson
Journal:  J Thromb Haemost       Date:  2008-05-22       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.